Primary endometrial adenocarcinoma, type I
Conditions
Interventions
FIGO Group:None
Sponsors
The affiliated hospital of southwest medical university
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Female patients aged 18-80 years; 2.Sample of patients diagnosed by histopathology as primary endometrial adenocarcinoma(type I)and graded by FIGO; 3.Patients who have not undergone chemotherapy; 4.Patients undergoing radical resection surgery; 5.The medical history information and diagnosis and treatment process are complete,detailed and truthful;
Exclusion criteria
Exclusion criteria: 1.Patients who have undergone chemotherapy; 2.Patients with malignant tumors of other organs that metastasize to the endometrium; 3.The patient also suffers from other serious diseases that may affect follow-up and short-term survival; 4.Information of medical history and treatment process are unknown; 5.Cases deemed unsuitable for participation in this study after comprehensive evaluation by the researchers;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oestrogen receptor-1; | — |
Secondary
| Measure | Time frame |
|---|---|
| Oestrogen receptor-1;Histology; | — |
Countries
China
Contacts
Public ContactZhang Cuiwei
The affiliated hospital of southwest medical university
Outcome results
None listed